Description

Epirubicin Amaxa (epirubicin) solution for injections 2 mg/ml. 25 ml. vial №1

Ingredients:

Epirubicin Amaxa solution for injections contains 2 mg of epirubicin per milliliter. Other ingredients may include citric acid, sodium chloride, and water for injection.

Dosage:

The dosage of Epirubicin Amaxa should be determined by a healthcare provider based on the patient’s condition, weight, and overall health. It is typically administered intravenously at a concentration of 2 mg/ml.

Indications:

Epirubicin Amaxa is indicated for the treatment of various cancers, including breast cancer, stomach cancer, and lung cancer. It works by inhibiting the growth of cancer cells.

Contraindications:

Epirubicin Amaxa is contraindicated in patients with a history of severe allergic reactions to anthracyclines, severe heart problems, or bone marrow suppression.

Directions:

Epirubicin Amaxa should only be administered by healthcare professionals experienced in chemotherapy in a clinical setting. It is given as an intravenous infusion over a specific period.

Scientific Evidence:

Studies have shown that epirubicin is effective in the treatment of various cancers. Research published in the Journal of Clinical Oncology demonstrated the efficacy of epirubicin in combination therapy for breast cancer patients.

Additional Information:

It is important to monitor patients receiving Epirubicin Amaxa for potential side effects such as bone marrow suppression and cardiac toxicity. Close medical supervision is necessary during treatment.

Epirubicin is a type of anthracycline chemotherapy drug that works by interfering with the DNA of cancer cells, preventing them from dividing and growing. This medication is commonly used in combination with other chemotherapy drugs to treat various types of cancer.

Clinical trials have shown that epirubicin, such as in Epirubicin Amaxa solution for injections, can significantly improve survival rates and reduce the risk of cancer recurrence in patients with early-stage breast cancer. The drug’s effectiveness has been well-documented in numerous studies, making it a cornerstone in cancer treatment protocols.